37.85
-0.55(-1.43%)
Currency In EUR
Address
Seestrasse 16
Kusnacht, 8700
Switzerland
Phone
41 44 267 67 00
Sector
Healthcare
Industry
Biotechnology
Employees
10
First IPO Date
June 29, 2020
| Name | Title | Pay | Year Born |
| Dr. Daniel Koller Ph.D. | Head of Biotech, Portfolio Manager and Member of Executive Board | 0 | 1970 |
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.